These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8901008

  • 1. Valproate and its major metabolite E-2-en-valproate induce different effects on behaviour and brain monoamine metabolism in rats.
    Löscher W, Hönack D.
    Eur J Pharmacol; 1996 Mar 28; 299(1-3):61-7. PubMed ID: 8901008
    [Abstract] [Full Text] [Related]

  • 2. Marked increase in anticonvulsant activity but decrease in wet-dog shake behaviour during short-term treatment of amygdala-kindled rats with valproic acid.
    Löscher W, Fisher JE, Nau H, Hönack D.
    Eur J Pharmacol; 1988 Jun 10; 150(3):221-32. PubMed ID: 3138139
    [Abstract] [Full Text] [Related]

  • 3. Sodium valproate induced alterations in monoamine levels in different regions of the rat brain.
    Baf MH, Subhash MN, Lakshmana KM, Rao BS.
    Neurochem Int; 1994 Jan 10; 24(1):67-72. PubMed ID: 8130737
    [Abstract] [Full Text] [Related]

  • 4. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studies.
    Löscher W, Wahnschaffe U, Hönack D, Wittfoht W, Nau H.
    Epilepsy Res; 1992 Dec 10; 13(3):187-98. PubMed ID: 1493781
    [Abstract] [Full Text] [Related]

  • 5. Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats.
    Semmes RL, Shen DD.
    Epilepsia; 1991 Dec 10; 32(2):232-41. PubMed ID: 2004628
    [Abstract] [Full Text] [Related]

  • 6. Can we develop improved derivatives of valproic acid?
    Bialer M, Haj-Yehia A, Badir K, Hadad S.
    Pharm World Sci; 1994 Feb 18; 16(1):2-6. PubMed ID: 8156045
    [Abstract] [Full Text] [Related]

  • 7. Effects of the NMDA receptor antagonist D-CPPene on extracellular levels of dopamine and dopamine and serotonin metabolites in striatum of kindled and non-kindled rats.
    Potschka H, Fedrowitz M, Löscher W.
    Eur J Pharmacol; 1999 Jun 18; 374(2):175-87. PubMed ID: 10422758
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.
    Löscher W, Fisher JE, Nau H, Hönack D.
    J Pharmacol Exp Ther; 1989 Sep 18; 250(3):1067-78. PubMed ID: 2506334
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of the competitive NMDA receptor antagonist, CGP 37849, on anticonvulsant activity and adverse effects of valproate in amygdala-kindled rats.
    Löscher W, Hönack D.
    Eur J Pharmacol; 1993 Apr 06; 234(2-3):237-45. PubMed ID: 8097722
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of morphine on 'wet-dog' shakes caused by cerebroventricular injection of serotonin.
    Drust EG, Sloviter RS, Connor JD.
    Pharmacology; 1979 Apr 06; 18(6):299-305. PubMed ID: 573908
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.